v3.26.1
Material Accounting Policies - Schedule of Share Capital Consisting Solely of Ordinary Shares (Details)
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
InflaRx GmbH [Member]    
Schedule of Share Capital Consisting Solely of Ordinary Shares [Line Items]    
Place of business/country of incorporation Jena and Munich, Germany  
Functional currency EUR  
Ownership interest held by the Company 100.00% 100.00%
Principal activities Operating subsidiary, R&D, holder of all IP  
InflaRx Pharmaceuticals, Inc. [Member]    
Schedule of Share Capital Consisting Solely of Ordinary Shares [Line Items]    
Place of business/country of incorporation Ann Arbor, MI, United States  
Functional currency USD  
Ownership interest held by the Company 100.00% 100.00%
Principal activities Operating subsidiary, R&D, US commercialization